If you havenât heard of Rising Phoenix yet, you will be hearing more about it in the coming days, weeks and months. In this Netflix documentary, âelite athletes and insiders reflect on the Paralympic Games and examine how they impact a global understanding of disability, diversity and excellence.â But itâs not just a story of … Continued
World Sight Day is an international “day of awareness,” coordinated by the International Agency for the Prevention of Blindness (IAPB). The purpose of World Site Day is to focus attention on the global issue of avoidable blindness and visual impairment. It is held each year on the second Thursday of October. This year, World Sight … Continued
Editor’s note: Recently, Steve Kelley wrote The Holy Grail of Braille and discussed exciting new refreshable braille technology including the Orbit Reader 20. Peer Advisor Sandra Burgess has been part of the testing program of that device and tells us about her experience in this informative post. Efforts to Make Braille More Affordable Braille is … Continued
CSUN, the annual Assistive Technology Conference, took place this month in sunny San Diego, and again, I participated "virtually," listening to podcasts and reading tweets of the products featured in between shoveling out from a series of late winter storms in southern Maine! For readers unfamiliar, CSUN is often a conference where new products, updates, … Continued
Treatments for Dry Macular Degeneration: An Unmet Need Age-Related Macular Degeneration (AMD) is the leading cause of legal blindness in Americans over 65. There are two distinct types of the disease, both of which result in the deterioration of the macula, the central part of the retina that allows a person to see fine detail. … Continued
Editor’s note: January is National Glaucoma Awareness Month, and VisionAware is bringing you critical information about management of this serious eye condition. Glaucoma is a diverse group of eye diseases that leads to a characteristic form of damage to the optic nerve. Elevated eye pressure is the primary known risk factor for glaucoma nerve damage … Continued
One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are now a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment remains elusive, although several potential treatments have emerged in recent years. Current … Continued
Low vision and blindness affect a substantial portion of the older adult population in the United States. Although new research from Johns Hopkins University School of Medicine indicates that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 … Continued
November is Diabetic Eye Disease Awareness Month, which aims to increase awareness of diabetes and diabetic eye disease and encourage people with diabetes to seek treatment for vision problems related to diabetes. You can learn more about diabetes at What Is Diabetes? and ÂżQuĂ© es la diabetes? at VisionAware. According to Prevent Blindness America, diabetes … Continued
New research from Johns Hopkins University School of Medicine reveals that the annual number of new cases of blindness and low vision among people aged 45 years and older is estimated to double during the next 30 years. Because data about the incidence of blindness and low vision in the United States was formally estimated … Continued